Alexander D Cross - Net Worth and Insider Trading
Alexander D Cross Net Worth
The estimated net worth of Alexander D Cross is at least $661,023 dollars as of 2024-11-08. Alexander D Cross is the Director of Ligand Pharmaceuticals Inc and owns about 5,083 shares of Ligand Pharmaceuticals Inc (LGND) stock worth over $660,282. Alexander D Cross is also the Director of Atossa Therapeutics Inc and owns about 494 shares of Atossa Therapeutics Inc (ATOS) stock worth over $741. Details can be seen in Alexander D Cross's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Alexander D Cross has not made any transactions after 2013-05-15 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Alexander D Cross
Alexander D Cross Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Alexander D Cross owns 3 companies in total, including Atossa Therapeutics Inc (ATOS) , Adhera Therapeutics Inc (ATRX) , and Ligand Pharmaceuticals Inc (LGND) .
Click here to see the complete history of Alexander D Cross’s form 4 insider trades.
Insider Ownership Summary of Alexander D Cross
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ATOS | Atossa Therapeutics Inc | 2013-05-15 | director |
| ATRX | Adhera Therapeutics Inc | 2005-07-20 | director |
| LGND | Ligand Pharmaceuticals Inc | 2006-09-27 | director |
Alexander D Cross Latest Holdings Summary
Alexander D Cross currently owns a total of 2 stocks. Among these stocks, Alexander D Cross owns 5,083 shares of Ligand Pharmaceuticals Inc (LGND) as of May 27, 2004, with a value of $660,282 and a weighting of 99.89%. Alexander D Cross also owns 494 shares of Atossa Therapeutics Inc (ATOS) as of May 15, 2013, with a value of $741 and a weighting of 0.11%.
Latest Holdings of Alexander D Cross
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| LGND | Ligand Pharmaceuticals Inc | 2004-05-27 | 5,083 | 129.90 | 660,282 |
| ATOS | Atossa Therapeutics Inc | 2013-05-15 | 494 | 1.50 | 741 |
Holding Weightings of Alexander D Cross
Alexander D Cross Form 4 Trading Tracker
According to the SEC Form 4 filings, Alexander D Cross has made a total of 0 transactions in Ligand Pharmaceuticals Inc (LGND) over the past 5 years. The most-recent trade in Ligand Pharmaceuticals Inc is the sale of 333 shares on May 27, 2004, which brought Alexander D Cross around $42,000.
According to the SEC Form 4 filings, Alexander D Cross has made a total of 0 transactions in Atossa Therapeutics Inc (ATOS) over the past 5 years. The most-recent trade in Atossa Therapeutics Inc is the acquisition of 3 shares on May 15, 2013, which cost Alexander D Cross around $2,745.
Insider Trading History of Alexander D Cross
- 1
Alexander D Cross Trading Performance
GuruFocus tracks the stock performance after each of Alexander D Cross's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Alexander D Cross is -16.7%. GuruFocus also compares Alexander D Cross's trading performance to market benchmark return within the same time period. The performance of stocks bought by Alexander D Cross within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Alexander D Cross's insider trading performs compared to the benchmark.
Performance of Alexander D Cross
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -11.19 | | | | | |
| Relative Return to S&P 500(%) | -9.26 | | | | | |
Alexander D Cross Ownership Network
Ownership Network List of Alexander D Cross
Ownership Network Relation of Alexander D Cross
Alexander D Cross Owned Company Details
What does Atossa Therapeutics Inc do?
Who are the key executives at Atossa Therapeutics Inc?
Alexander D Cross is the director of Atossa Therapeutics Inc. Other key executives at Atossa Therapeutics Inc include SVP & Finance and Accounting Heather Rees , CFO & General Counsel Kyle Guse , and director & 10 percent owner & Chief Scientific Officer Shu-chih Chen .
Atossa Therapeutics Inc (ATOS) Insider Trades Summary
Over the past 18 months, Alexander D Cross made no insider transaction in Atossa Therapeutics Inc (ATOS). Other recent insider transactions involving Atossa Therapeutics Inc (ATOS) include a net sale of 0 shares made by Gregory L Weaver , and a net purchase of 25,000 shares made by Jonathan Finn .
In summary, during the past 3 months, insiders sold 0 shares of Atossa Therapeutics Inc (ATOS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 50,000 shares of Atossa Therapeutics Inc (ATOS) were sold and 75,000 shares were bought by its insiders, resulting in a net purchase of 25,000 shares.
Atossa Therapeutics Inc (ATOS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Atossa Therapeutics Inc Insider Transactions
Alexander D Cross Mailing Address
Above is the net worth, insider trading, and ownership report for Alexander D Cross. You might contact Alexander D Cross via mailing address: C/o Ligand Pharmaceuticals Inc.,, 10275 Science Center Dr., San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
